# Rapport Therapeutics, Inc. (RAPP) - Q1 2026 earnings

Reported May 7, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $20.0M | $7.5M |
| EPS | $-0.42 | $-0.56 |

Earnings filing reader: [8-K 0001193125-26-210324](https://www.opencapital.sh/filings/0001193125-26-210324)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-210324.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/2012593/000119312526210324/0001193125-26-210324-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/2012593/000119312526210355/0001193125-26-210355-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/rapp/earnings/q1-2026